Medicare now covers GLP-1 weight-loss drugs – here's what it costs

Starting this week, Medicare in the US has expanded coverage of GLP-1 drugs such as Ozempic and Wegovy to include weight loss, not just conditions like Type 2 diabetes, sleep apnea, or heart-attack risk. Millions of Americans are now eligible for coverage. The exact out-of-pocket cost depends on the individual's Medicare plan.